Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Heart Failure
Interventions: DRUG: Trastuzumab|DRUG: Pertuzumab|DRUG: Trastuzumab emtansine
Sponsor: Population Health Research Institute